5Beeker KL, Snider R, Nylen ES. Preealeition assay in systemic in- flammation, infection, and sepsis: clinical utility and limitations [ J ]. Crit Care Med,2008,36(3 ) :941 -952.
6Simon L, Gauvin F, Amre DK, et al: Serum procalcitonin and C- reactive protein levels as markers of bacterial infection : a systematic review and meta-analysis[ J]. Clin Infect Dis, 2004, 39:206-217; erratum 2005,40 : 1386.
7Chris-Crain M, Muller B. Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators [ J ]. Eur Respir J,2007:30 (3) :556 - 573.
8Beovic B, Krefl S, Osredkar J, et al Serum PCT levels in patients with mild community- aquired pneuminia[ J]. Clin Microbiol Infect, 2005, 11(12): 1050-1051.
9Jereb M, Kotar T. Usefulness of procalcitonin to differentiate typical from atypical community-acquired pneumonia [ J ]. Wien Klin Wochenschr, 2006, 118(5-6): 170-174.
10Franzin L, Cabod D. Legionella pneumonia and serum procalcitonin [J]. Curr Microbio, 2005, 50( 1 ): 43-46.
3Dupuy AM, Terrier N. Is C-reactive protein a marker of inflam-mation. Nephrology, 2003,24(7) : 337-341.
4Krüger S,Ewig S,Marre R,et al.Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes[J].Eur Respir J,2008(2):349-355.
5Krisofferson KB,Sogaard OS,Wejse C,et al.Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission-a randomized trial[J].Clin Microbiol Infect,2009,15:481-487.
6Philipp S,Mirjam CC.Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections:the ProHOSP randomized controlled trial[J].JAMA,2009,302(10):1059-1066.
7Christ-Crain M, Stolz D, Bingisser R, et al. Procalcitonin guidance of an- tibiotic therapy in community-acquired pneumonia: A randomizedtrial [J]. Am J Respir Crit Care Med,2006,17g(1) :84 -93.
8Schuetz P, Chfist-CrainM, WolbersM, et al. Pmcalcitonin guided antibi- otic therapy and hospitalization in patientswith lower respira-tory tract in- fections: a prospective, multicenter, randomized con-trolled trial [ J ]. BMC Health ServRes,2007,7 : 102.
9Christ-Crain M, Opal SM. Clinical review:the role of biomarkers in the diagnosis and management of community-acquired pneumonia [ J ]. Crit Care ,2010,14 ( 1 ) :203.
10Brown SM, Jones BE, Jephson AR, et al. Validation of the Infec- tious disease society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia [ J ]. Crit Care Med, 2009,37 ( 12 ) :3010 - 3016.
